ACS ES&T air · 2026
Novel Approach to Assess the Toxicity of PM2.5 on a Subway Platform Using a Mobile Air-Liquid Interface System and Submerged Exposure.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Introna Micol, Juárez-Facio Ana Teresa, Vallabani Naga Veera Srikanth, Tu Minghui, Norman Michael, Silvergren Sanna, Colombo Andrea, Liboni Valentina, Tsyupa Bozhena, Mancini Alessandro, Olofsson Ulf, Steimer Sarah Sulamith, Karlsson Hanna Lovisa, Elihn Karine
Аннотация
Subway stations are enclosed environments that can have elevated concentrations of PM2.5 (particulate matter with an aerodynamic diameter of <2.5 μm). These particles are primarily generated by mechanical wear from trains and are therefore rich in transition metals and suspected to affect health upon inhalation. To simulate real-world inhalation scenarios, this study aimed to assess the toxicity of airborne subway PM2.5 using a mobile air-liquid interface (ALI) exposure system directly on the platform, using monoculture (A549) and coculture (A549 + dTHP-1) cell models, alongside laboratory submerged exposures. In ALI exposures, a dose of 0.12 ± 0.07 μg/cm2 could not induce any change in cell viability or inflammatory markers after 24 h of incubation. In submerged experiments, a higher dose was applied than in ALI, inducing a decrease in cell viability in both A549 and dTHP-1 cells. A549 cells exhibited increased IL-6 and TNF-α release at the highest dose (100 μg/mL). In dTHP-1 cells, IL-8 release was significantly elevated even at the lowest dose (10 μg/mL), and all four cytokines (IL-8, IL-6, IL-1β, and TNF-α) were significantly increased at 100 μg/mL. These findings highlight the critical role of exposure conditions in toxicological studies and support the use of both in situ and laboratory-based approaches. Moreover, longer in situ exposures may be necessary to achieve doses comparable to those in a laboratory setup for comparison.